dimethyl sulfoxide (rimso) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Dimethyl sulfoxide (DMSO) is a clear odorless liquid, inexpensively produced as a by-product of the paper industry. It is widely available in the USA as a solvent but its medical use is currently restricted by the FDA to the palliative treatment of interstitial cystitis and to certain experimental applications. In medicine, DMSO is also used as a topical analgesic, a vehicle for topical application of pharmaceuticals, as an anti-inflammatory, and an antioxidant.   NCATS

Chemistry

  • SMILES: C[S+](C)[O-]
  • InChIKey: IAZDPXIOMUYVGZ-UHFFFAOYSA-N
  • Mol. Mass: 78.133
  • ALogP: -0.01
  • ChEMBL Molecule:
    dimethyl sulfoxide  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$7.3230
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

(ch3)2so | demavet | demsodrox | dimethyli sulfoxidum | dimethyl sulfone | dimethyl sulfone, 13c-labeled | dimethylsulfoxid | dimethyl sulfoxide | dimethylsulfoxyde | dimethyl sulfur oxide | dimethyl sulphoxide | dimetil sulfoxido | dmso | domoso | infiltrina | methylsulfinylmethane | methyl sulfoxide | rimso 50 | rimso-50 | s(o)me2 | sq-9453 | sulfinylbis(methane) | syntexan

Organizations (16)

Research & Development (15)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (12)

Approved Indications (1)


 

Cystitis, Interstitial (approved 1978)

Experimental Indications - Clinical Trial Phases 1-4 (12)


 

Breast Diseases (Phase 2/Phase 3)

Breast Neoplasms (Phase 2)

Cystitis, Interstitial (Phase 2)

Dentist-Patient Relations (Phase 1)

Dimethyl Sulfoxide (Phase 2/Phase 3)

Melanoma (Phase 1)

Radiodermatitis (Phase 2)

Urinary Bladder (Phase 3)

Urinary Bladder Diseases (Phase 2)

Urinary Bladder, Overactive (Phase 3)

Urinary Incontinence (Phase 3)

Urinary Incontinence, Urge (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial Organizations: 15

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue